Wedbush cuts Avalo Therapeutics target price to $22 from $34
AVTX•Wedbush cut its target price for Avalo Therapeutics to $22 from $34.
Related News
CION proposes $25 million anchor investment in Pearl PIPE financing
CION•
Lithia & Driveway target price cut to $469 from $488 by Exane BNP Paribas
LAD•
Germany's higher tax revenue estimates will not offer more fiscal leeway, minister says
EWG•
AMEX halts trading; last price 9.08
COHC•
Roper rises after raising FY2026 profit forecast
ROP•